Poly(lactide-co-glycolide) microencapsulation of vaccine antigens.
Fimbriae from Bordetella pertussis have been encapsulated in poly(lactide-co-glycolide) (PLG) microspheres of a size appropriate for oral administration. The binding of antibodies which react with conformational or linear fimbrial epitopes, to fimbriae released from microspheres, suggested that the process of was not detrimental to the native integrity of the protein. Mice were immunised by oral gavage with a single dose of microencapsulated fimbriae, or with fimbriae adsorbed onto alhydrogel and administered by intraperitoneal injection. The resulting immune responses in serum were comparable but only oral administration of microencapsulated fimbriae elicited specific immune responses in external secretions. Six weeks after immunisation, both groups of immunised animals were protected against challenge with live B. pertussis.
Jones
D H
DH
Microbial Antigens Department, Centre for Applied Microbiology and Research, Salisbury, Wilts, UK.
McBride
B W
BW
Farrar
G H
GH
D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis / Q000096:biosynthesis; D000917:Antibody Formation; D000942:Antigens, Bacterial / Q000008:administration & dosage*; D001428:Bacterial Vaccines / Q000008:administration & dosage*; D001886:Bordetella pertussis / Q000276:immunology*; D002214:Capsules; D004797:Enzyme-Linked Immunosorbent Assay; D000939:Epitopes; D005260:Female; D010861:Fimbriae, Bacterial; D007070:Immunoglobulin A / Q000032:analysis / Q000096:biosynthesis; D007074:Immunoglobulin G / Q000032:analysis / Q000096:biosynthesis; D051379:Mice; D008863:Microspheres; D011098:Polyglactin 910; D012463:Saliva / Q000276:immunology; D014917:Whooping Cough / Q000276:immunology / Q000517:prevention & control*
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D001428:Bacterial Vaccines; D002214:Capsules; D000939:Epitopes; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D011098:Polyglactin 910